Search

everythinglearnresearchcommunity

for

Search:↓

ZO-1 helps hair follicle stem cells renew better by changing their structure.

Insulin sensitizers may slightly reduce hirsutism but are less effective than other treatments.

Some synthetic carbohydrate receptors, especially compounds 3 and 15, show strong potential for treating Zika virus.

Atorvastatin reversed memory problems caused by cancer drug trastuzumab and improved its cancer-fighting abilities without causing hair loss.

Acyzol could help treat conditions caused by zinc deficiency.

Janus Kinase inhibitors are effective and have an acceptable safety profile for treating moderate to severe Ulcerative Colitis.

Proteasome inhibitors are promising treatments for various cancers, autoimmune diseases, and other conditions.

Repurposing existing drugs for COVID-19 shows promise but requires more research to confirm effectiveness.

Excessive eyelash growth from erlotinib may indicate positive tumor response and help treat madarosis.

The document concludes that fexofenadine reduces inflammation in chronic hives, cholestyramine helps half of pregnant women with itchy rashes, and relaxing incisions are a good alternative in facial surgery for the elderly.

Entospletinib effectively prevents eye and skin GVHD in mice.

Some newly made compounds are promising for treating enlarged prostate, hair loss, viruses, and prostate cancer, and might be better than current drugs.

Topical human epidermal growth factor may effectively treat acne caused by cancer medication.

Interferon α‐2b can temporarily reduce hepatitis C virus and normalize liver enzyme levels.

Prescription tablets treat hirsutism, while over-the-counter foams treat hypertrichosis.

Sorafenib helps some advanced cancers alone or with other treatments, but not all, and research continues to improve its use.

EGFR-TKIs can cause significant skin, nail, and organ side effects.

The contraceptive reduced hair growth and altered hormone levels in hirsute women.

Using finasteride and doxazosina together works better for treating benign prostatic hyperplasia than using just one.

The cancer drugs bortezomib and lenalidomide cause skin side effects in many patients.

JAK inhibitors help treat some diseases but may increase risks of blood clots and cancer in certain patients.

PROTO1 and PROTO2 protect against hearing damage.

A brominated phenoxy compound effectively inhibits a human enzyme and shows potential for clinical use.

Research on HIV-1 capsid inhibitors has progressed significantly, with the U.S. leading in contributions.

Early diagnosis and treatment are crucial for CAPS, and Eculizumab can be effective.

Immune checkpoint inhibitors can increase the risk of autoimmune skin diseases, especially bullous pemphigoid.